| Market Capitalization (Millions $) |
129 |
| Shares
Outstanding (Millions) |
127 |
| Employees |
130 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-57 |
| Cash Flow (TTM) (Millions $) |
-19 |
| Capital Exp. (TTM) (Millions $) |
2 |
Business Description
Nautilus Biotechnology Inc. is a life sciences company based in California, United States. The company focuses on developing and commercializing novel tools and technologies for the analysis of proteins and their functions. Their aim is to advance the understanding of human biology and enable more effective drug discovery and development.
Nautilus Biotechnology has developed a high-throughput, single-molecule protein analysis platform called the Nautilus Proteomic Discovery Platform. This platform combines imaging, protein tagging, and sequencing technologies to enable the study of proteins at an unprecedented level of detail. It has the potential to revolutionize the field of proteomics by providing comprehensive insights into protein structure, function, and interactions.
By providing a comprehensive view of the proteome, Nautilus Biotechnology's technology can help uncover new therapeutic targets, identify disease mechanisms, and accelerate the development of precision medicines. The company collaborates with academic institutions, biotech companies, and pharmaceutical companies to apply their platform in various areas of research and drug discovery.
Nautilus Biotechnology was founded in 2016 by a team of experienced scientists and entrepreneurs. Since its inception, the company has raised significant funding from investors and has attracted renowned scientific and business advisors. With its innovative technology and focus on protein analysis, Nautilus Biotechnology aims to make significant contributions to the field of life sciences.
Company Address: 2701 Eastlake Avenue East Zagreb 98102 City of Zagreb
Company Phone Number: 333-2001 Stock Exchange / Ticker: NASDAQ NAUT
|
